ClinicalTrials.gg
RecruitingNCT07594444Updated Oct 15, 2026

Whey Protein and Adaptogenic Supplementation in Physically Active Females

An interventional study of Whey protein and Whey Protein With Adaptogenic Blend in Sports Nutritional Sciences, Recovery and Muscle Strength Recovery, sponsored by Sports Performance and Applied Research in Trials and Analysis. Recruiting at 1 site in United Kingdom. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by Sports Performance and Applied Research in Trials and Analysis · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.
Updated Oct 15, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 390 studies in Motor Activity with a site in United Kingdom — 65 open to participants now, 79 under way, none of them phase 3. Motor Activity · United Kingdom.

Planned enrollment
104th of 318
60 · median 42
Started
2026
with 16 others
No phase
292 of 390
50 open now
Primary completion
2026-11
later than 48 of 78 live
Registered
382nd of 390
by date

Among the 390 studies in Motor Activity with a site in United Kingdom, this one is the 104th largest by planned enrollment of the 318 interventional ones that give a count, is one of 17 that started in 2026, is one of 292 with no phase, reaches primary completion later than 48 of the 78 other live ones, and was the 382nd registered.

Motor Activity

9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.

Browse Motor Activity studies →

Open to participants now

65 of the 390 studies in Motor Activity with a site in United Kingdom are open now. Recruiting first, the newest first:

59 more — sign in →

All 65 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 18 Years to 45 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 390 studies in Motor Activity with a site in United Kingdom, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn whether whey protein or plant protein supplements, with or without an adaptogenic herb blend, can improve strength, recovery, stress, and wellbeing in active females. The adaptogenic blend contains ashwagandha root extract and shatavari root extract.

The main questions the study aims to answer are:

  • Do whey protein and plant protein supplements improve muscle strength and recovery in physically active females?
  • Does adding ashwagandha and shatavari improve stress, recovery, sleep, and wellbeing compared with protein alone?
  • Are there differences between whey protein and plant protein when combined with the adaptogenic blend?

Researchers will compare four supplement groups:

  • Whey protein
  • Whey protein with ashwagandha and shatavari
  • Plant protein
  • Plant protein with ashwagandha and shatavari

Participants will:

  • Take their assigned supplement daily for 6 weeks
  • Attend testing sessions before and after the intervention
  • Complete questionnaires about recovery, sleep, stress, soreness, and digestive health
  • Provide saliva samples to measure stress, hormone, immune, and inflammation markers
  • Complete muscle strength tests, including handgrip strength and push-up testing
  • Complete a 24-hour dietary recall. The study includes physically active females aged 18 to 45 years who regularly participate in structured training.
03

Conditions studied

  • Sports Nutritional Sciences
  • Recovery
  • Muscle Strength Recovery
  • Muscle Strength
  • Supplements

Browse trials for

Keywords

  • Whey Protein
  • Plant protein
  • Ashwagandha
  • Shatavari
  • Adaptogens
  • Sports
  • Exercise
  • Active females
  • physically active females
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female, aged 18-45 years
  • Currently participating in regular structured athletic or physical training (≥3 sessions per week)
  • Free from musculoskeletal injury that would prevent testing
  • Willing to maintain usual diet and training habits during the study
  • Not currently using protein supplements or adaptogenic supplements

Exclusion criteria

Exclusion Criteria:

  • Pregnant, breastfeeding, or planning pregnancy during the study period
  • Known allergy or sensitivity to dairy, pea protein, pumpkin seed, chia seed, ashwagandha, shatavari, or nightshades
  • Current use of prescribed medication that may interact with the supplements
  • Thyroid disorders, conditions, hormone-sensitive conditions, or other medical conditions that may be affected by supplementation
  • Diagnosed eating disorder or condition affecting protein metabolism
  • Current musculoskeletal injury preventing participation in testing
  • Current use of other protein supplements or adaptogens
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Whey protein

    Participants will consume a whey protein supplement daily for 6 weeks. Assessments of muscle strength, recovery, stress, wellbeing, dietary intake, and salivary biomarkers will be conducted at baseline and post-intervention.

    Dietary Supplement: Whey protein

  • Experimental
    Whey Protein + Adaptogenic Blend

    Participants will consume a whey protein supplement containing ashwagandha KSM-66® (250 mg) and shatavari SRI-81™ (300 mg) daily for 6 weeks. Assessments will be conducted at baseline and post-intervention.

    Dietary Supplement: Whey Protein With Adaptogenic Blend

  • Active comparator
    Plant protein

    Participants will consume a plant-based protein supplement daily for 6 weeks. Assessments of muscle strength, recovery, stress, wellbeing, dietary intake, and salivary biomarkers will be conducted at baseline and post-intervention.

    Dietary Supplement: Plant Protein Supplement

  • Experimental
    Plant Protein + Adaptogenic Blend

    Participants will consume a plant-based protein supplement containing ashwagandha KSM-66® (250 mg) and shatavari SRI-81™ (300 mg) daily for 6 weeks. Assessments will be conducted at baseline and post-intervention.

    Dietary Supplement: Plant Protein With Adaptogenic Blend

Interventions

  • Dietary supplementWhey ProteinsStudies of Whey ProteinsWhey Proteins pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Participants will consume a whey protein supplement daily for 6 weeks. The supplement will be provided in identical blank tubs. Participants will be instructed to maintain their usual diet and training habits throughout the intervention period.

    Also known as: Grass-Fed Whey Protein, Whey Protein Powder

  • Dietary supplementWhey Protein With Adaptogenic Blend

    Participants will consume a whey protein supplement containing ashwagandha KSM-66® root extract (250 mg) and shatavari SRI-81™ root extract (300 mg) daily for 6 weeks. Supplements will be provided in identical blank tubs. Participants will maintain usual diet and training habits during the study.

    Also known as: Ashwagandha and Shatavari Whey Protein, Whey Protein Plus Adaptogens

  • Dietary supplementPlant Protein Supplement

    Participants will consume a plant-based protein supplement daily for 6 weeks. The supplement will be provided in identical blank tubs. Participants will be instructed to maintain their usual diet and training habits throughout the intervention period.

    Also known as: Plant-Based Protein, Vegan Protein Supplement

  • Dietary supplementPlant Protein With Adaptogenic Blend

    Participants will consume a plant-based protein supplement containing ashwagandha KSM-66® root extract (250 mg) and shatavari SRI-81™ root extract (300 mg) daily for 6 weeks. Supplements will be provided in identical blank tubs. Participants will maintain usual diet and training habits during the study.

    Also known as: Plant Protein Plus Adaptogens, Ashwagandha and Shatavari Plant Protein

06

What researchers measure

Primary outcomes

  1. Salivary Cortisol Concentration

    Change in salivary cortisol concentration from baseline to post-intervention following 6 weeks of whey protein or plant protein supplementation with or without an adaptogenic herb blend containing ashwagandha KSM-66® and shatavari SRI-81™. Results will be reported in ng/mL.

    Time frame: Baseline and Week 6

Secondary outcomes

  1. Handgrip Strength

    Change in maximal handgrip strength measured using a CAMRY dynamometer from baseline to post-intervention.

    Time frame: Baseline and Week 6

  2. Upper Body Muscular Endurance

    Change in upper body muscular endurance assessed using the 90-degree push-up test protocol from baseline to post-intervention.

    Time frame: Baseline and Week 6

  3. Perceived Recovery and Wellbeing

    Participants will complete the Hooper Index Questionnaire, which assesses four domains: sleep quality, fatigue, stress, and muscle soreness. Each domain is rated on a 10-point Likert scale ranging from 1 to 10, with total scores ranging from 4 to 40. Higher scores indicate poorer wellbeing and recovery status, whereas lower scores indicate better perceived wellbeing and recovery.

    Time frame: Baseline and Week 6

  4. Salivary DHEA-S Concentration

    Salivary DHEA-S concentration will be measured from saliva samples using enzyme-linked immunosorbent assay (ELISA) techniques. Results will be reported in ng/mL.

    Time frame: Baseline and Week 6

  5. Perceived Gastrointestinal Health

    Change in gastrointestinal symptoms and digestive comfort assessed using a gastrointestinal distress questionnaire.

    Time frame: Baseline and Week 6

  6. Dietary Intake

    Dietary intake assessed using a 24-hour dietary recall to evaluate habitual nutritional intake during the study period.

    Time frame: Baseline and Week 6

  7. Salivary Oestradiol Concentration

    Salivary oestradiol concentration will be measured from saliva samples using ELISA. Results will be reported in pg/mL.

    Time frame: Baseline and Week 6

  8. Salivary Secretory Immunoglobulin A (sIgA) Concentration

    Salivary secretory immunoglobulin A (sIgA) concentration will be measured from saliva samples using ELISA. Results will be reported in µg/mL.

    Time frame: Baseline and Week 6

  9. Salivary C-reactive Protein Concentration

    Salivary C-reactive protein will be measured from saliva samples using ELISA. Results will be reported in pg/mL.

    Time frame: Baseline to Week 6

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared with other researchers. Data collected in this study will be anonymised and retained only for the duration of analysis before permanent deletion, in accordance with the study protocol, participant consent, and UK GDPR requirements.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Nov 2026, 4 months after the start.

Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 4 months is below that.

Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 15, 2026: primary completion Aug 2026 → Nov 2026 and completion Sep 2026 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 12, 2026
First posted
May 18, 2026
StartActual
Jul 1, 2026
Primary completionEst.
Nov 20, 2026was Aug 2026
CompletionEst.
Dec 1, 2026was Sep 2026
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Aug 12, 2026→Nov 20, 2026
Oct 15, 2026
Study completion
Sep 20, 2026→Dec 1, 2026
Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    Primary completion Aug 12, 2026→Nov 20, 2026
    Study completion Sep 20, 2026→Dec 1, 2026
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07594444
Lead sponsor
Sports Performance and Applied Research in Trials and Analysis
Responsible party
Olivia Charlotte Coope (Research Scientist, Sports Performance and Applied Research in Trials and Analysis) — Principal investigator
First posted
May 18, 2026
Start date
Jul 1, 2026
Primary completion
Nov 20, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Oct 15, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion